RxDoctor Payments Data

James Wurzer, MD

Radiation Oncology · Egg Harbor Township, NJNPI 1659311934

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.

$698in general payments, 2019–2025

Across 27 payments — averaging $25.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$156
  • Johnson & Johnson$91
  • Bayer$81
  • Myriad Genetic Laboratories, Inc.$68
  • Novartis$49
  • Siemens Medical Solutions USA, Inc.$44
  • plus $209 from 11 others
$4,500in research payments, 2019–2025

Across 4 payments — averaging $1125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Accuray Incorporated$5K

What the payments were for

  • Food & beverage$698100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$698 in reported general payments places this provider in the 60th percentile of 132 radiation oncology providers in New Jersey.

See all radiation oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,193,509
Medicare patients
1,096
Services billed
13,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron13$6,694
Tamsulosin Hcl252$5,818
Dexamethasone68$1,173
Pilocarpine Hcl14$608
Silver Sulfadiazine38$381
Lidocaine Hcl ViscousLidocaine Hcl32$348
Finasteride16$314
Prednisone54$262
SsdSilver Sulfadiazine17$183
Methylprednisolone23$116
Ciprofloxacin Hcl22$73
Oxycodone Hcl15$68
Cephalexin22$62
Fluconazole12$51
Alprazolam15$33

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Egg Harbor Township

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →